Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ANI Pharmaceuticals, Inc. - Common Stock
(NQ:
ANIP
)
72.82
-1.32 (-1.78%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 27, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ANI Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
ANI Pharmaceuticals Earnings Perspective: Return On Capital Employed
↗
March 13, 2023
Via
Benzinga
ANI Pharmaceuticals Reports Record Fourth Quarter Financial Results and Achieves Full Year 2022 Revenue Milestone; Initiates 2023 Guidance
March 09, 2023
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
Guggenheim Creates Bullish Pitch For ANI Pharma On Progress With Cortrophin Launch
↗
March 01, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023
↗
March 01, 2023
Via
Benzinga
ANI Pharmaceuticals's Return On Capital Employed Overview
↗
December 12, 2022
Via
Benzinga
ANI Pharmaceuticals: Q2 Earnings Insights
↗
August 08, 2022
ANI Pharmaceuticals (NASDAQ:ANIP) reported its Q2 earnings results on Monday, August 8, 2022 at 06:50 AM. Here's what investors need to know about the announcement.
Via
Benzinga
ANI Pharmaceuticals to Discuss Fourth Quarter and Full Year 2022 Financial Results on March 9, 2023, at 8:30 a.m. ET
February 22, 2023
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
Organon Stock Scores Market Leadership With Jump To 83 RS Rating
↗
January 17, 2023
Organon sees its Relative Strength Rating reach the 80-plus level.
Via
Investor's Business Daily
ANI Pharmaceuticals Announces the FDA Approval and Launch of Levocarnitine Tablets USP
December 19, 2022
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals Announces the FDA Approval and Launch of Fluoxetine Oral Solution USP
November 28, 2022
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
November 16, 2022
Via
Benzinga
ANI Pharmaceuticals Announces the FDA Approval and Launch of Trimethoprim Tablets USP
November 16, 2022
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals Reports Third Quarter 2022 Financial Results; Reports Record Net Revenues
November 09, 2022
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals to Discuss Third Quarter 2022 Financial Results on November 9, 2022, at 8:00 a.m. ET
October 24, 2022
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals Appoints Krista Davis as Chief Human Resources Officer
September 12, 2022
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
↗
September 07, 2022
Upgrades
Via
Benzinga
ANI Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference
August 30, 2022
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals Announces the Launch of Prochlorperazine Maleate Tablets USP
August 29, 2022
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
↗
August 16, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
August 16, 2022
Via
Benzinga
ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Dexamethasone Tablets USP
August 16, 2022
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals Reports Second Quarter 2022 Financial Results; Reports Record Net Revenues and Raises Full-Year 2022 Net Revenue Guidance for Purified Cortrophin® Gel
August 08, 2022
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals Announces the Launch of Acebutolol Hydrochloride Capsules USP
August 03, 2022
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals Acquires ANDAs from Oakrum Pharma, LLC
July 28, 2022
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals to Discuss Second Quarter 2022 Financial Results on August 8, 2022, at 8:00 a.m. ET
July 25, 2022
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals Appoints Meredith W. Cook as SVP, General Counsel and Corporate Secretary
July 18, 2022
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Clorazepate Dipotassium Tablets USP
June 22, 2022
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals's Return On Capital Employed Overview
↗
June 08, 2022
According to data from Benzinga Pro, during Q1, ANI Pharmaceuticals's (NASDAQ:ANIP) reported sales totaled $64.48 million. Despite a 16.6% increase in earnings, the company posted a loss of $20.13...
Via
Benzinga
ANI Pharmaceuticals Announces Consolidation of Manufacturing Network, Capturing Operational Synergies Post Novitium Acquisition
June 02, 2022
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
ANI Pharmaceuticals Announces the FDA Approval and Imminent Launch of Fludrocortisone Acetate Tablets USP
June 01, 2022
From
ANI Pharmaceuticals, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
